From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Is the Servision $2m subscription RNS just a massive spoof?

By Nigel Somerville, the Deputy Sheriff of AIM | Friday 24 February 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Tom Winnifrith has already driven a coach and horses through the deal announced on Wednesday whereby an obscure US-based outfit has apparently agreed to throw $2 million (and up to a further $4 million) into AIM-listed Servision (SEV) at a massive premium to the share price previous to the announcement. But a no-one-is-watching o’clock RNS last night leaves me wondering whether the whole thing is so appallingly dressed up as to render the original RNS a gross misrepresentation of the truth.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:46:51